Hydroxycinnamic acid

Other Names

2-hydroxycinnamic acid2-propenoic acid, 3-(4-hydroxyphenyl)-3,4-dihydroxycinnamic acid3,5-dimethoxy-4-hydroxycinnamic acid3-(4-hydroxyphenyl)-2-propenoic acid3-hydroxycinnamic acid3-hydroxyphenylacrylic acid3-methoxy-4-hydroxycinnamic acid4-coumaric acid4-hydroxy-3,5-dimethoxycinnamic acid4-hydroxy-3-methoxycinnamic acid4-hydroxycinnamic acid5-caffeoylquinic acidC6-C3 phenylpropanoidcaffeic acidcaftaric acidchicoric acidchlorogenic acidcoumaric acidcoutaric acidcurcumindiferuloylmethanefertaric acidferulic acidHCAHCAshydroxy derivative of cinnamic acidhydroxycinnamatehydroxycinnamateshydroxyphenylacrylic acidm-coumaric acido-coumaric acidp-coumaric acidp-cumaric acidp-hydroxycinnamic acidp-hydroxyphenylacrylic acidpara-coumaric acidphenolic acidphenylpropanoidphenylpropanoid acidrosmarinic acidsinapatesinapic acidsinapinatesinapinic acid

Synopsis

Hydroxycinnamic Acid: A Comprehensive Reference

1. Identity: Chemistry, Nomenclature, and Classification

Hydroxycinnamic acids (HCAs) are a group of phytonutrients — plant-derived compounds that have numerous beneficial effects on human health — and are one of the most naturally abundant classes of phenolic compounds. Structurally, they possess a C6–C3 skeleton, exemplified by molecules such as the parent compound hydroxycinnamic acid (also known as p-coumaric acid), as well as caffeic, ferulic, and sinapic acids. Broadly speaking, they can be defined as compounds derived from cinnamic acid.

Hydroxybenzoic and hydroxycinnamic acids are a class of organic compounds in which one of the hydrogen atoms on the benzene ring is replaced by a hydroxyl (–OH) or alkoxyl group (–O–R). HCAs are important natural phenolic compounds abundantly present in various foods, including fruits, vegetables, cereals, coffee, tea, and wine, and are synthesized via the shikimate pathway, possessing a phenylpropanoic acid C6–C3 core skeletal structure.

The principal members of the hydroxycinnamic acid family are:

p-Coumaric acid (trans-4-hydroxycinnamic acid; CAS 501-98-4)
Caffeic acid (3,4-dihydroxycinnamic acid; CAS 331-39-5)
Ferulic acid (4-hydroxy-3-methoxycinnamic acid; CAS 1135-24-6)
Sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid; CAS 530-59-6)
Chlorogenic acid (5-O-caffeoylquinic acid; CAS 327-97-9) — an ester of caffeic acid and quinic acid that occurs in various isomers, with 5-O-caffeoylquinic acid (5-CQA) being the most abundant form in plant-based foods and beverages.
Rosmarinic acid — a caffeic acid ester found abundantly in the Lamiaceae family

Hydroxycinnamic acid derivatives are an important class of polyphenolic compounds originating from the Mevalonante–Shikimate biosynthesis pathway in plants, with members including cinnamic acid, p-coumaric acid, ferulic acid, caffeic acid, chlorogenic acid, and rosmarinic acid.

The biosynthetic process starts from the deamination of phenylalanine or tyrosine amino acids, through the intervention of phenylalanine ammonia-lyase (PAL) and tyrosine ammonia-lyase (TAL) enzymes: PAL produces cinnamic acid, which is then converted to p-coumaric acid, while TAL directly generates p-coumaric acid. p-Coumaric acid is then oxidised to caffeic acid, whose O-methylation by S-adenosyl methionine (SAM) leads to ferulic acid.

The methylation of hydroxycinnamic acids is an important enzymatic reaction in the biosynthesis of lignin in all vascular plants. HCA compounds (p-coumaric, caffeic acid, ferulic acid) occur most frequently as simple esters with hydroxy carboxylic acids or glucose. The glycosylated derivatives or esters of quinic, shikimic, or tartaric acid of hydroxycinnamic acids are found as bound forms instead of free existence, but phenolic acids of pomegranate, coffee, and blueberries occur as esters or glycosides conjugated with other natural compounds such as flavonoids, alcohols, hydroxy fatty acids, and sterols.

2. Natural Sources and Distribution

Hydroxycinnamic acids are the most widely distributed phenolic acids in plants. They are present at high concentrations in many food products, including fruits, vegetables, tea, cocoa, and wine. Hydroxycinnamic acids belong to one of the families of nonflavonoid phenols present in fruit (kiwis, blueberries, apples, grapes, coffee) and cereal grains (wheat, rice, oat flours), with caffeic acid, coumaric acid, and ferulic acid being the most abundant in nature.

p-Hydroxycinnamic acids (HCAs), including ferulic, caffeic, sinapic, and p-coumaric acids, possess a characteristic phenylpropanoid C6–C3 backbone and account for about one-third of the phenolic compounds in our diet.

Key dietary sources by compound include:

Ferulic acid: Rice bran is one of the richest sources (in bound form); oats and barley retain more ferulic acid; coffee contains both free and bound forms; fruits including apples, pears, oranges, and cherries have modest levels. Ferulic acid also occurs in exceptionally high concentrations in popcorn and bamboo shoots.
Caffeic acid: It is found in fruits, tea, coffee, oil, spices, and vegetables. Caffeic acid is isolated and purified from green and roasted coffee sources.
Chlorogenic acid: Chlorogenic acid is found in rich concentrations in many plants such as green coffee beans. Diverse plant families contain chlorogenic acids in different tissues, including various health-promoting foods such as vegetables, grapes, apples, pears, and citrus fruits, and commonly consumed beverages such as coffee, green tea, and wine.
p-Coumaric acid: p-Coumaric acid is a cinnamic acid derivative found in several fruits, vegetables, and herbs.

Hydroxycinnamic acid compounds occur most frequently as simple esters with hydroxy carboxylic acids or glucose. Phenolic acid compounds seem to be universally distributed in plants. Furthermore, phenolic acids may occur in food plants as esters or glycosides conjugated with other natural compounds such as flavonoids, alcohols, hydroxy fatty acids, sterols, and glucosides. Also, hydroxycinnamic acid amides appear to be common constituents.

3. Traditional and Historical Use

Caffeic acid and its derivatives have been used for many centuries due to their natural healing and medicinal properties. Because HCAs are not isolated compounds in traditional practice but are constituents of medicinal plants, their historical use is necessarily described in terms of the botanical preparations that contain them.

Traditional Chinese Medicine (TCM)

Ferulic acid, a phenolic substance widely existing in plants, is an important active component of many traditional Chinese medicines, and it has been proved to have a variety of biological activities, especially in relation to oxidative stress, inflammation, vascular endothelial injury, fibrosis, apoptosis, and platelet aggregation. Ferulic acid is a key bioactive component in traditional medicinal plants including Angelica sinensis and Asafoetida. Ferulic acid (chemically known as 3-methoxy-4-hydroxycinnamic acid) is derived from herbs such as Angelica sinensis and Radix Paeoniae Alba.

Cinnamic acid has received great attention in oriental research, where it has been used as an antioxidant in food additives in Asia, and especially in medical studies in China, after being proven to be an effective component of medicinal herbs used by traditional medicine.

Traditional Chinese medicine (TCM) and Ayurveda traditions have pharmacologically used many plant species with a high content of chlorogenic acids.

Islamic and Middle Eastern Traditional Medicine

Hydroxycinnamic acids are the most widely distributed phenolic acids in plants. Cinnamic acid has many uses in medicine, perfumes, polymers, cosmetics, and agriculture. The ScienceDirect chapter Hydroxycinnamic Acids: Natural Sources, Biosynthesis, Possible Biological Activities, and Roles in Islamic Medicine specifically documents HCA-containing plant use within the Islamic medical tradition.

European Herbal Traditions

Herbs high in HCA derivatives were integrated into European herbal practice over centuries. In traditional herbal medicine, plants rich in hydroxycinnamic acids were frequently used to treat digestive disorders, alleviate inflammation, and support cardiovascular health. For instance, rosemary, sage, and oregano — herbs high in rosmarinic acid (a hydroxycinnamic acid derivative) — have long been brewed into teas or applied as poultices for their healing effects.

General Dietary History

Hydroxycinnamic acids — including caffeic acid, ferulic acid, and p-coumaric acid — are found abundantly in fruits, vegetables, grains, and beverages such as coffee and wine. Historically, these compounds have been consumed as part of traditional diets rich in plant-based foods, and their presence has been associated with various health benefits attributed to such diets.

4. Key Constituents and Established Mechanisms of Action

4.1 Antioxidant and Radical-Scavenging Activity

Hydroxycinnamic acids are important phytochemicals possessing significant biological properties. Hydroxycinnamic acids and their derivatives act as antioxidants that neutralize reactive oxygen species (ROS) and free radicals. The high content of hydroxyl and phenolic groups in their structure allows them to donate hydrogen atoms, effectively neutralizing free radicals.

Most reports indicate that the presence of an unsaturated bond on the side chain of HCAs is vital to their activity. The structural features reported to be of importance to the antioxidant activity include modifications of the aromatic ring — alterations in the number and position of hydroxy groups and insertion of electron-donating or -withdrawing moieties — as well as modifications of the carboxylic function, including esterification and amidation processes. Most investigations concluded that the presence of an ortho-dihydroxy phenyl group (catechol moiety) is of significant importance to the antioxidant activity, while the presence of three hydroxy groups does not necessarily improve the activity.

Ferulic and caffeic acids have concentration-dependent antioxidant effects in terms of inhibition of lipid peroxidation and reactive oxygen species scavenging. Importantly, studies indicate that some dietary compounds may have concentration-dependent antioxidant or prooxidant activities.

4.2 Anti-Inflammatory Mechanisms

It is well known for polyphenols to display anti-inflammatory activity in vitro and in vivo by targeting inflammatory mediators, including numerous cytokines (TNF-α, interleukins), leukotrienes, and different enzymes (cyclooxygenases, inducible nitric oxide synthase [iNOS]). For instance, chlorogenic, caffeic, and ferulic acids showed potent antioxidant and anti-inflammatory activities through the down-regulation of the LPS-induced expression of iNOS or COX-2 in RAW 264.7 macrophages.

Ferulic acid exerts anti-inflammatory effects through regulation of inflammatory cytokine levels; modulation of signaling pathways such as NF-κB, MAPK, and JAK/STAT; amelioration of oxidative stress; and regulation of immune cell homeostasis.

In adipose tissues, hydroxycinnamic acid derivatives inhibit macrophage infiltration and NF-κB activation in obese animals.

4.3 Metabolic Mechanisms

p-Coumaric acid possesses strong antioxidant and anti-inflammatory properties, making it a promising compound for managing metabolic and inflammatory diseases. p-CA has been shown to neutralize free radicals and diminish oxidative stress by enhancing hepatic fatty acid oxidation and increasing fecal lipid excretion.

Many studies have shown that ferulic acid can inhibit the PI3K/AKT pathway, the production of ROS, and the activity of aldose reductase. The anti-inflammatory effect of ferulic acid is mainly related to the levels of PPARγ, CAM, NF-κB, and p38 MAPK signaling pathways. Ferulic acid not only protects vascular endothelium by ERK1/2 and NO/ET-1 signaling but also plays an anti-fibrotic role via the TGF-β/Smad and MMPs/TIMPs systems. Moreover, ferulic acid has anti-apoptotic and anti-platelet effects.

4.4 Neuroprotective Mechanisms

Ferulic acid, also known as 3-methoxy-4-hydroxycinnamic acid, is an active ingredient in TCM that inhibits β-amyloid (Aβ) aggregation and has antioxidant and anti-inflammatory effects. FA derivatives have been reported to have low toxicity, high biological activity, and high blood-brain barrier permeability.

Chlorogenic acid has shown diverse neuroprotective effects on various neuropathological conditions, which may be exerted through inhibition of neuroinflammation, reduction in ROS production, prevention of oxidation, and suppression of neuronal apoptosis. CGA inhibits H₂O₂-induced apoptosis by blocking pro-apoptotic factors caspase-3 and PARP and upregulating anti-apoptotic factors Bcl-2 and Bcl-X(L) in neuronal cells.

4.5 Gut Microbiota and Intestinal Barrier Mechanisms

HCAs protect the intestinal barrier through four mechanisms: preserving tight junction proteins (TJPs), modulating pro-inflammatory cytokines, exerting antioxidant activity, and regulating the intestinal microbiota.

Approximately 90% of polyphenols in the human diet are not absorbed in the small intestine but instead undergo decomposition and transformation by microorganisms residing in the colon, leading to the generation of active molecules that can exert biological effects.

5. Pharmacokinetics and Bioavailability

Many health-beneficial effects have been acknowledged in food products rich in HCAs; however, food processing, dietary intake, bioaccessibility, and pharmacokinetics have a high impact on whether HCAs reach the target tissue in order to exert their biological activities. Metabolism is of high importance since HCAs' metabolites could either lose the activity or be even more potent compared to the parent compounds.

Hydroxycinnamic acids are the main phenolic acids in the western diet. Harmonizing the available information on the absorption, distribution, metabolism, and excretion (ADME) of HCAs is fundamental to unraveling the compounds responsible for their health effects. A systematic review including forty-seven intervention studies with coffee, berries, herbs, cereals, tomato, orange, grape products, and pure compounds identified up to 105 HCA metabolites, mainly acyl-quinic and C6–C3 cinnamic acids. C6–C3 cinnamic acids, such as caffeic and ferulic acid, reached the highest blood concentrations (maximum plasma concentration [Cmax] = 423 nM), with Tmax values ranging from 2.7 to 4.2 h.

Major metabolic reactions, enzymes, and organs involved in HCA metabolism include uridine-5′-diphosphate-glucuronosyltransferase (UGT), catechol-O-methyltransferase (COMT), and sulfotransferase (SULT).

Studies show that ferulic acid is rapidly absorbed but exhibits low bioavailability, mainly due to the influence of metabolic pathways and food matrix characteristics. FA's low solubility and rapid metabolism limit its bioavailability, and nanoencapsulation and other delivery systems are being investigated to overcome these challenges.

The metabolism of HCAs has been intensively studied in Lactobacillus spp., as the metabolic transformation of HCAs by these bacteria contributes to the biological activity of these acids. The main mechanisms used by Lactobacillus spp. to metabolize HCAs are enzymatic decarboxylation and/or reduction.

6. Scientific Evidence by Area of Use

6.1 Cardiovascular Health

A diet rich in hydroxycinnamic acids is thought to be associated with beneficial health effects such as a reduced risk of cardiovascular disease.

Chlorogenic acid and blood pressure (clinical evidence): Chlorogenic acid extracted from green coffee was tested for its efficacy in lowering blood pressure in hypertensive patients. A double-blind, randomized clinical trial on 117 subjects — in which the intervention group received different quantities of CGA extract for 28 days compared to a placebo group — showed that the extract markedly reduced blood pressure without any adverse effects.

Mechanistic and preclinical evidence: CGA controls hypertension by reducing ROS through the attenuation of NAD(P)H-dependent superoxide. This effect inhibits the proliferation of smooth muscle cells in vitro as well as in vivo by decreasing angiotensin-converting enzyme activity, thus modulating the renin-angiotensin-aldosterone system. Ferulic acid, a CGA metabolite, has a considerable effect on blood pressure reduction. Its administration enhances acetylcholine-induced vasodilation and increases the bioavailability of NO in the arterial vasculature.

Chlorogenic acid is considered one of the most important dietary phenolic compounds, exhibiting wide-ranging biological activities including cardioprotective effects and modulation of lipid and glucose metabolism.

Evidence strength note: Phenolcarboxylic acids such as caffeic acid, chlorogenic acid, p-coumaric acid, and ferulic acid are reported to exert beneficial effects on human health through prevention of degenerative pathologies such as cardiovascular diseases. However, most mechanistic evidence remains preclinical; the 117-subject chlorogenic acid RCT represents one of the stronger clinical data points in this area.

6.2 Glucose Metabolism and Type 2 Diabetes

The estimated dietary intake of chlorogenic acid is 5 to 1000 mg/day. Chlorogenic acid is widely present in plant foods and plays a role in regulating glucose and lipid metabolism, improving insulin resistance, and reducing the risk of type 2 diabetes and cardiovascular diseases.

Clinical dosage data: Based on data from population intervention studies, daily oral doses of CGA at 13.5 mg to 1200 mg can reduce fasting blood glucose (FBG), improve glucose tolerance, enable weight loss or prevent weight gain, and improve blood pressure in hypertensive patients. Daily intake of 200 mg or more may reduce FBG, with a dose-effect relationship in the range 13.5–500 mg/day; a specific proposed level of CGA to improve FBG could be ≥200 mg/day.

Example clinical trial: A randomized, double-blind, placebo-controlled clinical trial was carried out in 30 patients with impaired glucose tolerance. The intervention group received 400 mg capsules of chlorogenic acid, three times daily one half-hour before meals for 90 days. Outcomes evaluated included 2-hour plasma glucose, glycated hemoglobin (A1C), triglycerides, HDL, fasting glucose, blood pressure, body weight, BMI, waist circumference, total cholesterol, LDL, VLDL, creatinine, and liver enzymes.

Human and animal studies have confirmed that CGA can dramatically lower total cholesterol and total triglyceride levels. In overweight patients, taking CGA twice a day can improve blood glucose, insulin sensitivity, and other metabolic parameters.

Evidence strength note: Clinical data for chlorogenic acid on glucose metabolism are promising but drawn mostly from small trials; larger, longer-term RCTs are still needed.

6.3 Neuroprotection and Neurodegenerative Disease

Owing to the limited pharmacological options for Alzheimer's disease (AD), novel strategies based on the consumption of polyphenols have been addressed to prevent or slow down AD progression. Ferulic acid is a hydroxycinnamic acid derivative known to be endowed with many bioactivities, especially antioxidant, anti-inflammatory, and antidiabetic, thus suggesting it could be exploited as a possible novel neuroprotective strategy.

Many preclinical studies show that ferulic acid displays neuroprotective effects in AD models. A systematic review and meta-analysis including a total of 344 animals in 12 papers examined the effects, mechanisms, and clinical prospects of FA in AD treatment.

Hydroxycinnamic acid derivatives are polyphenols abundant in cereals, coffee, tea, wine, fruits, vegetables, and other plant-based foods. To aid in the clinical prevention and treatment of Parkinson's disease (PD), in vivo investigations confirmed the pharmacological properties of HCDs relevant to PD.

As an active natural substance, chlorogenic acid exerts diverse therapeutic effects, particularly in conditions associated with chronic metabolic diseases and age-related disorders, showing multidimensional functions including neuroprotection for neurodegenerative disorders. Mechanistically, its integrative functions act through modulation of anti-inflammation/oxidation and metabolic homeostasis.

Evidence strength note: The clinical translation of ferulic acid is hindered by bottlenecks such as low bioavailability and insufficient human clinical data. Future research should prioritize developing novel drug delivery systems and conducting large-scale clinical trials to facilitate clinical translation. The neuroprotective evidence for HCAs remains predominantly preclinical.

6.4 Cancer Biology

Hydroxycinnamic acids are plant compounds with anticancer potential due to their antioxidant, anti-inflammatory, apoptosis-inducing, and proliferation-inhibiting effects. Studies have shown that HCAs, such as caffeic acid, ferulic acid, and sinapic acid, inhibit the growth of cancer cells in vitro and in vivo, and sensitize cancer cells to chemotherapy and radiation therapy.

Caffeic acid (50 µM) decreased the number of viable cells in several cancer cell lines studied. Antiproliferative action of caffeic acid, sinapic acid, ferulic acid, and other HCAs was studied on T47D human breast cancer cells, showing a time- and dose-dependent inhibitory effect on cell growth.

In vitro studies in the HepG2 liver cancer model demonstrated that p-hydroxycinnamic acid at concentrations of 10–1000 nM suppressed colony formation and growth of HepG2 cells. Mechanistically, p-HCA decreased levels of Ras, PI3K, Akt, MAPK, NF-κB p65, and β-catenin, and increased levels of retinoblastoma and regucalcin. Furthermore, culturing with p-HCA stimulated cell death due to increased caspase-3 levels.

Several studies have demonstrated that HCAs exhibit selective toxicity, with a higher propensity to induce cell death in cancerous cells compared to normal cells. However, the toxicity profile of HCAs can vary depending on the specific compound, dosage, and experimental conditions.

Evidence strength note: High doses of HCAs and their derivatives induced growth arrest and apoptosis in a variety of tumor cells by triggering mitochondrial dysfunction or the mitochondria-dependent apoptotic pathway. Despite undoubted protective effects or anticancer efficacy in preclinical models, clinical trials have failed to establish a link between treatment with HCAs and cancer reduction, although this may be due to insufficient dosages to specific tissues. Cancer evidence is predominantly preclinical (cell culture and animal studies); direct human clinical trial evidence is lacking.

6.5 Metabolic Syndrome, Lipid Metabolism, and Obesity

Several simple phenolic compounds such as p-coumaric acid, ferulic acid, caffeic acid, chlorogenic acid, and rosmarinic acid belong to the hydroxycinnamic acid class, and these compounds possess potent antioxidant and anti-inflammatory properties. These compounds also showed potential therapeutic benefit in experimental diabetes and hyperlipidemia, and recent evidence suggests they may serve as valuable molecules for the treatment of obesity-related health complications.

Chlorogenic acid shows multidimensional functions including mitigation of cardiovascular disorders, diabetes mellitus, and liver and kidney injuries.

6.6 Gut Health and Intestinal Barrier Function

HCAs protect the intestinal barrier through preserving tight junction proteins, modulating pro-inflammatory cytokines, exerting antioxidant activity, and regulating the intestinal microbiota.

Although there is currently no direct evidence of immune modulation by caffeic acid from human clinical studies, molecular mechanism analysis has revealed that caffeic acid significantly inhibits the mRNA levels of Caspase-1 and NLRP3 in radiation-induced intestinal injury models.

Evidence strength note: Gut barrier evidence for HCAs is predominantly in vitro and animal-based; human intervention data are very limited.

6.7 Anti-inflammatory Applications (Rheumatoid Arthritis and Colitis)

Ferulic acid is a key bioactive component in traditional medicinal plants including Angelica sinensis and Asafoetida. Accumulating evidence supports its therapeutic efficacy in inflammatory disorders such as rheumatoid arthritis (RA) and ulcerative colitis (UC). Preclinical studies show that ferulic acid has low toxicity and good safety, demonstrating potential for development as a novel anti-inflammatory agent.

6.8 Skin and Cosmeceutical Applications

Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is used as a component of natural origin in many cosmetic products. Hydroxycinnamic acids and their derivatives display antioxidant, anti-collagenase, anti-inflammatory, antimicrobial, and anti-tyrosinase activities, as well as ultraviolet (UV) protective effects, suggesting they can be exploited as anti-aging and anti-inflammatory agents, preservatives, and hyperpigmentation-correcting ingredients.

Due to their poor stability, easy degradation, and oxidation, microencapsulation techniques have been employed for topical application. Based on available findings, hydroxycinnamic acids present high cosmetic potential, but studies addressing the validation of their benefits in cosmetic formulations are still scarce.

In recent years, hydroxycinnamic acids and their derivatives have gained significant attention in the pharmaceuticals field due to their remarkable biological activities including UV protection, antioxidative properties, anti-inflammatory effects, and antibacterial qualities.

7. Body Systems Associated with Hydroxycinnamic Acids

Cardiovascular system: Antihypertensive effects, modulation of ACE activity, vasodilation, anti-platelet aggregation, and anti-atherosclerotic properties (primarily via chlorogenic and ferulic acids)
Central nervous system: Neuroprotection against Aβ aggregation, anti-neuroinflammatory activity, potential applications in AD and PD models
Gastrointestinal system: Gut microbiota modulation, intestinal barrier integrity preservation via tight junction protection
Metabolic/endocrine system: Glucose homeostasis improvement, insulin sensitization, lipid-lowering effects
Immune system: Caffeic, ferulic, and p-coumaric acids exhibited an immunomodulatory effect that could be ascribed, in part, to their cytoprotective effect via their antioxidant capacity, with immunomodulatory activity concomitant with the cellular antioxidant effect in macrophages and splenocytes.
Skin/integumentary system: UV photoprotection, anti-aging (anti-collagenase), anti-pigmentation
Oncology (preclinical): Antiproliferative, pro-apoptotic, and chemosensitizing activities in multiple cancer cell lines

8. Dosage Forms and Reported Dosages

Isolated forms of HCAs have gained interest in the pharmaceutical field due to their pharmacological activities demonstrated by in vitro and in vivo studies, including analgesic, antibacterial, anti-cancer, anti-diabetic, antifungal, anti-hyperlipidemic, anti-hypertension, anti-inflammatory, antimutagenic, anti-obesity, antioxidant, anti-tyrosinase, immunomodulatory, neuroprotective, and photoprotective activities.

HCAs are commercially available in several forms:

Pure isolated compounds (pharmaceutical-grade powders)
Standardized plant extracts (e.g., green coffee bean extract standardized to chlorogenic acid content)
Nanoparticle and microencapsulation formulations (for improved bioavailability)
Cosmetic preparations (serums, creams, UV-protective formulations)

Reported dosages from intervention studies (sources only):

Chlorogenic acid (glucose/metabolic outcomes): Based on population intervention studies, daily oral doses of CGA at 13.5 mg to 1200 mg have been studied for reduction of fasting blood glucose, improvement of glucose tolerance, weight management, and blood pressure improvement in hypertensive patients.
Chlorogenic acid (antihypertensive trial): In a randomized, double-blind clinical trial on 117 subjects, different quantities of CGA extract were administered over 28 days.
Chlorogenic acid (impaired glucose tolerance trial): A double-blind, placebo-controlled trial in 30 patients used 400 mg capsules of chlorogenic acid three times daily (1,200 mg/day total), one half-hour before meals, for 90 days.
Ferulic acid (preclinical/cell culture): Effective ferulic acid concentrations in cell culture research range from 10 nM to 1 mM without toxic reactions in a variety of cell lines.

It is essential to distinguish between the use of HCAs as dietary supplements and as therapeutic agents, as the dosage and formulation suitable for dietary supplements may be insufficient for therapeutic purposes. The regulatory and practical implications of using HCAs in these different contexts require careful consideration. Further research is needed to determine appropriate dosages, formulations, long-term effects, and regulatory frameworks.

9. Safety Considerations and Interactions

9.1 General Safety Profile

Preclinical studies show that ferulic acid has low toxicity and good safety. The biological properties of HCAs are distinctive, as they combine antioxidant, anti-inflammatory, and metabolic functions, which can be utilized for therapeutic purposes in humans.

9.2 p-Coumaric Acid Toxicity at High Doses

Regarding toxicity, p-coumaric acid is generally considered safe at dietary levels, but high doses have been associated with mild hepatotoxic and nephrotoxic effects. In ICR mice, intraperitoneal administration of 500 mg/kg p-CA significantly reduced glutathione (GSH) levels in the liver and kidney.

9.3 Concentration-Dependent Pro-Oxidant Effects

Studies indicate that some dietary compounds may have concentration-dependent antioxidant or prooxidant activities. Ferulic and caffeic acids demonstrate such concentration-dependent antioxidant effects in terms of inhibition of lipid peroxidation and reactive oxygen species scavenging. This dual nature — antioxidant at physiological concentrations, potentially pro-oxidant at supraphysiological doses — is an established pharmacological consideration for HCAs.

9.4 Bioavailability Limitations and Food Matrix Effects

Pharmacokinetic data from plant extract studies suggest that the presence of other plant constituents may influence the pharmacokinetics of p-CA, possibly by modulating its absorption or metabolism. Food processing, dietary intake, bioaccessibility, and pharmacokinetics have a high impact on whether HCAs reach the target tissue. Metabolism is of high importance since HCA metabolites could either lose the activity or be even more potent compared to the parent compounds.

9.5 Drug Interaction Considerations

Ferulic acid not only protects vascular endothelium via ERK1/2 and NO/ET-1 signaling but also plays an anti-platelet role. This anti-platelet activity of ferulic acid and certain HCAs is relevant to interactions with anticoagulant or antiplatelet pharmaceutical agents, though direct human pharmacodynamic interaction studies are scarce in the published literature.

9.6 Cosmetic and Topical Use Stability

Due to poor stability, easy degradation, and oxidation of HCAs, microencapsulation techniques have been employed for topical application, preventing them from degradation and enabling sustained release.

9.7 Evidence Gaps

Very few studies report clinical trials, kinetics studies, and the ability of nanoparticles to cross biological membranes in order to fully confirm cosmeceutical benefits. Further research is needed to determine appropriate dosages, formulations, long-term effects, and regulatory frameworks for HCAs as both dietary supplements and therapeutic agents.

References

Health Conditions

Health conditions that Hydroxycinnamic acid may help support.

No conditions available.

Body Systems

Body systems that Hydroxycinnamic acid may help support.

No body systems available.